FOLLI, FRANCO
FOLLI, FRANCO
Dipartimento di Scienze della Salute
The Relationship of Glucose Intolerance/Diabetes and Overweight/Obesity with Sphingolipidoma Alterations
2024 C. Morano, L. Centofanti, M.V. DEI CAS, S. Penati, E. Bianco, M. Bignotto, C. Berra, P. Zermiani, R. Paroni, P.M. Battezzati, F. Folli
Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population. CA.ME.LI.A study 7 year follow-up
2024 M. Bignotto, E. Bianco, L. Centofanti, A. Russo, M. Dei Cas, P. Zermiani, C. Morano, F. Samartin, E. Bertolini, F. Bifari, C. Berra, M. Zuin, R. Paroni, P.M. Battezzati, F. Folli
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide
2024 M.E. Lunati, V. Cimino, D. Bernasconi, A. Gandolfi, P.S. Morpurgo, C. Tinari, E. Lazzaroni, L. Baruffaldi, M. Muratori, L. Montefusco, I. Pastore, A. Rossi, I.G. Franzetti, F. Muratori, R. Manfrini, O.E. Disoteo, R. Terranova, P. Desenzani, A. Girelli, R. Ghelardi, F. D'Addio, M. Ben Nasr, C. Berra, F. Folli, L. Bucciarelli, P. Fiorina
Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study
2024 C. Berra, R. Manfrini, F. Bifari, E. Cipponeri, R. Ghelardi, L. Centofanti, U. Mortola, E. Lunati, L. Bucciarelli, V. Cimino, F. Folli
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial
2024 M. Fava, S.M. Stahl, L. Pani, S.D. Martin, A.J. Cutler, V. Maletic, C.W. Gorodetzky, F.J. Vocci, F.L. Sapienza, T.R. Kosten, C. Kröger, P. Champasa, C. O'Gorman, C. Guidetti, A. Alimonti, S. Comai, A. Mattarei, F. Folli, D. Bushnell, S. Traversa, C.E. Inturrisi, P.L. Manfredi, M. Pappagallo
Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis
2024 A. Galli, S. Moretti, N. Dule, E.S. Di Cairano, M. Castagna, P. Marciani, C. Battaglia, F. Bertuzzi, I. Pastore, P. Fiorina, S. La Rosa, A. Davalli, F. Folli, C. Perego
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule
2024 M. Ben Nasr, V. Usuelli, S. Dellepiane, A.J. Seelam, T.V. Fiorentino, F. D'Addio, E. Fiorina, C. Xu, Y. Xie, H.B. Balasubramanian, E. Castillo-Leon, L. Loreggian, A. Maestroni, E. Assi, C. Loretelli, A. Abdelsalam, B. El Essawy, S. Uccella, I. Pastore, M.E. Lunati, G. Sabiu, A. Petrazzuolo, G. Ducci, E. Sacco, L. Centofanti, M. Venturini, S. Mazzucchelli, D. Mattinzoli, M. Ikehata, G. Castellano, G. Visner, L. Kaifeng, K.M. Lee, Z. Wang, D. Corradi, S. La Rosa, S. Danese, J. Yang, J.F. Markmann, G.V. Zuccotti, R. Abdi, F. Folli, P. Fiorina
Investigating the Impact of Epstein-Barr Virus on Sphingolipid Composition in Extracellular Vesicles of Multiple Sclerosis Patients
2024 L. Centofanti, A. Zollo, M. Dei Cas, V. Citro, D. Giannandrea, E. Soleymaninejadian, A. Mingione, A. Corona, A. Priori, M. Miozzo, F. Folli, R. Paroni, R. Chiaramonte, F. Martinelli Boneschi
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017)
2024 C. Guidetti, S.D. Martin, G. Serra, M. Apicella, L. Pani, M. Pappagallo, A. Mattarei, F. Folli, P. Manfredi, M. Fava
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets
2023 F. Folli, G. Finzi, R. Manfrini, A. Galli, F. Casiraghi, L. Centofanti, C. Berra, P. Fiorina, A. Davalli, S. La Rosa, C. Perego, P.B. Higgins
Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis
2023 F. Folli, L. Centofanti, S. Magnani, E. Tagliabue, M. Bignotto, L. La Sala, A.E. Pontiroli
Effect of Prolonged and Substantial Weight Loss on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis
2023 A.E. Pontiroli, L. Centofanti, C. Le Roux, S. Magnani, E. Tagliabue, F. Folli
Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder
2023 C. Guidetti, G. Serra, L. Pani, M. Pappagallo, G. Maglio, S. De Martin, A. Mattarei, F. Folli, P. Manfredi, M. Fava
Effetti benefici su parametri antropometrici e metabolici in ragazzi in sovrappeso e obesi dopo un intervento nutrizionale-comportamentale di un anno
2023 M. Tosi, I.A. Matelloni, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi, F. Folli
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users
2023 M.J. Shram, J.E. Henningfield, G. Apseloff, C.W. Gorodetzky, S. De Martin, F.L. Vocci, F.L. Sapienza, T.R. Kosten, J. Huston, A. Buchhalter, J. Ashworth, R. Lanier, F. Folli, A. Mattarei, C. Guidetti, S. Comai, C. O’Gorman, S. Traversa, C.E. Inturrisi, P.L. Manfredi, M. Pappagallo
Multiple beneficial effects of 1-year nutritional-behavioral intervention on anthropometric and metabolic parameters in overweight and obese boys
2023 M. Tosi, I.A. Matelloni, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi, F. Folli
AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus
2023 C. Berra, R. Manfrini, M. Mirani, L. Bucciarelli, A.S. Zakaria, S. Piccini, R. Ghelardi, M.E. Lunati, S. Rodovalho, F. Bifari, P. Fiorina, F. Folli
Beneficial effects on anthropometric and metabolic parameters in overweight and obese boys after 1 year nutritional-behavioral intervention
2023 F. Folli, M. Tosi, I.A. Matelloni, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi
Delayed puberal development in obese males: possible role of hypogonadotropic hypogonadism
2023 F. Pecori Giraldi, M. Mancini, F. Diana, I.A. Matelloni, A. Rossi, M. Tosi, F. Folli
Effetti benefici sui parametri antropometrici e metabolici nei ragazzi sovrappeso e obesi dopo 1 anno di intervento nutrizionale-comportamentale
2023 I.A. Matelloni, M. Tosi, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi, F. Folli